Design Therapeutics DSGN Income Statement (2020-2026)

NASDAQ DSGN
$12.62 +0.26 (+2.10%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Design Therapeutics Quarterly Income Statement

Periods 26 quarters
Latest Jun 2026

Design Therapeutics reported net income of -$20.16M for the quarter ended Jun 2026. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & Cost
Revenue
Interest income
Interest Income - Total
3.29M3.25M3.21M3.04M2.70M2.49M2.31M2.17M2.07M2.01M
Operating Items
Research & DevelopmentR&D
8.54M7.34M8.76M11.29M14.30M14.26M15.73M17.06M13.26M11.01M9.80M10.52M11.88M12.16M15.38M15.74M14.59M13.43M14.38M16.39M
Share-based Compensation (IS)
1.24M1.56M2.36M2.62M2.87M3.08M3.43M3.72M3.22M2.72M3.18M3.30M3.12M3.54M
Selling, General & AdministrativeSG&A
2.80M3.79M4.61M4.34M4.89M5.14M5.92M5.53M5.57M4.11M4.60M4.53M4.37M4.54M5.04M5.83M4.72M4.74M5.33M5.79M
Other Operating ExpensesOther Opex
2.21M2.27M2.64M2.54M2.74M2.27M2.19M2.40M3.22M
Operating ExpensesOpex
11.34M11.13M13.37M15.64M19.19M19.39M21.65M22.60M18.82M15.12M14.40M15.04M16.25M16.69M20.42M21.57M19.31M18.17M19.71M22.18M
Operating IncomeOp. Inc
-11.34M-11.13M-13.37M-15.64M-19.19M-19.39M-21.65M-22.60M-18.82M-15.12M-14.40M-15.04M-16.25M-16.69M-20.42M-21.57M-19.31M-18.17M-19.71M-22.18M
EBIT
-11.34M-11.13M-13.37M-15.64M-19.19M-19.39M-21.65M-22.60M-18.82M-15.12M-14.40M-15.04M-16.25M-16.69M-20.42M-21.57M-19.31M-18.17M-19.71M-22.18M
Non-operating items
Interest & Investment IncomeInt & Inv Inc
3.29M3.25M3.21M3.04M2.70M2.49M2.31M2.17M2.07M2.01M
Other Non Operating IncomeOther Non Op Inc.
0.02M0.06M0.10M0.64M1.49M2.05M2.36M2.66M3.03M3.28M3.29M3.25M3.21M
Net income details
EBT
-11.34M-11.13M-13.37M-15.64M-19.19M-19.39M-21.65M-22.60M-18.82M-15.12M-11.11M-11.79M-13.04M-13.65M-17.71M-19.08M-17.00M-16.00M-17.64M-20.16M
Profit After TaxPAT
-11.34M-11.13M-13.37M-15.64M-19.19M-19.39M-21.65M-22.60M-18.82M-15.12M-11.11M-11.79M-13.04M-13.65M-17.71M-19.08M-17.00M-16.00M-17.64M-20.16M
Income from Continuing OperationsIncome (Continuing)
-11.34M-11.13M-13.37M-15.64M-19.19M-19.39M-21.65M-22.60M-18.82M-15.12M-11.11M-11.79M-13.04M-13.65M-17.71M-19.08M-17.00M-16.00M-17.64M-20.16M
Consolidated Net IncomeConsol Net Inc.
-11.34M-11.13M-13.37M-15.64M-19.19M-19.39M-21.65M-22.60M-18.82M-15.12M-11.11M-11.79M-13.04M-13.65M-17.71M-19.08M-17.00M-16.00M-17.64M-20.16M
Income towards Parent CompanyParent Net Inc
-11.32M-11.06M-13.27M-15.00M-17.70M-17.34M-19.29M-19.94M-15.79M-11.84M-11.11M-11.79M-13.04M-13.65M-17.71M-19.08M-17.00M-16.00M-17.64M-20.16M
Net Income towards Common StockholdersNet Income
-11.32M-11.06M-13.27M-15.00M-17.70M-17.34M-19.29M-19.94M-15.79M-11.84M-11.11M-11.79M-13.04M-13.65M-17.71M-19.08M-17.00M-16.00M-17.64M-20.16M
Additional items
EPS (Basic)
-0.21-0.24-0.24-0.27-0.32-0.31-0.35-0.36-0.28-0.21-0.20-0.21-0.23-0.24-0.31-0.34-0.30-0.28-0.29-0.32
EPS (Diluted)
-0.21-0.24-0.24-0.27-0.32-0.31-0.35-0.36-0.28-0.21-0.20-0.21-0.23-0.24-0.31-0.34-0.30-0.28-0.29-0.32
Shares Outstanding
55.16M45.94M55.51M55.67M55.78M55.71M55.91M55.95M55.99M55.98M56.49M56.56M56.62M56.59M56.76M56.86M56.95M57.33M61.43M62.51M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
55.16M45.94M55.51M55.67M55.78M55.71M55.91M55.95M55.99M55.98M56.49M56.56M56.62M56.59M56.76M56.86M56.95M57.33M61.43M62.51M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
55.22M45.94M55.62M55.72M55.84M55.90M55.92M55.98M56.00M56.47M56.49M56.62M56.62M56.75M56.77M56.95M56.96M60.40M62.44M62.58M
EBITDA
-11.31M-11.04M-13.29M-15.55M-19.08M-19.27M-21.52M-22.46M-18.68M-14.98M-14.26M-14.89M-16.09M-16.55M-20.26M-21.42M-19.16M-18.01M-19.55M-22.03M

Design Therapeutics Income Statement API

Pull Design Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=DSGN&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY